Vesalius BioCapital Partners invests in companies active in human health through venture capital funds raised.
Phone:
1B rue Thomas Edison
L-1445
Luxembourg
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-04-16 | SWORD Health | Seed VC - III | $4.6M | Green Innovations |
| 2017-11-17 | Ncardia | Series B | $12.38M | Epimede, InnovationQuarter, Sambrinvest, Societe Federale de Participations et dInvestissement - Federale Participatie-en Investeringsmaatschappij, and Société Régionale d'Investissement de Wallonie |
| 2017-10-04 | OMEICOS Therapeutics | Series B - II | High-Tech Grunderfonds, KfW, Remiges Ventures, SMS Investments, and VC Fonds Technologie | |
| 2017-03-01 | OMEICOS Therapeutics | Series B | $8.76M | Ascenion, Falck Group, High-Tech Grunderfonds, KfW, SMS Investments, and VC Fonds Technologie |
| 2017-01-05 | Exact Imaging | Series C | $16.23M | BioSciKin, iGan Partners, Lumira Capital, and PMV |
